GWAS |
|
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Bitter beverage consumption ( 31046077)
- Bitter non-alcoholic beverage consumption ( 31046077)
- Blood metabolite levels ( 24816252)
- Caffeine consumption ( 21490707)
- Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level) ( 27702941)
- Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio) ( 27702941)
- Coffee consumption ( 31345160 21357676 29367735 31046077 25288136)
- Coffee consumption (cups per day) ( 25288136)
- Cutaneous squamous cell carcinoma ( 27424798)
- Estimated glomerular filtration rate ( 31152163)
- Inflammatory bowel disease ( 26192919)
- Lung cancer in ever smokers ( 28604730)
- Metabolic traits ( 21886157)
- Microalbuminuria ( 31511532)
- Plasma kynurenine levels in major depressive disorder ( 29317604)
- Rosacea symptom severity ( 29771307)
- Severe influenza A (H1N1) infection ( 26379185)
- Sweet beverage consumption ( 31046077)
- Tea consumption ( 31046077)
- Ulcerative colitis ( 26192919)
- Urinary albumin excretion ( 30220432)
- Urinary albumin excretion (no hypertensive medication) ( 30220432)
- Urinary albumin-to-creatinine ratio ( 31630189 30910378 31511532)
- Urinary potassium excretion ( 31409800)
- Urinary sodium excretion ( 31409800)
|